119 related articles for article (PubMed ID: 15216953)
1. Hospital-acquired candidemia in HIV-infected patients. Incidence, risk factors and predictors of outcome.
Bertagnolio S; de Gaetano Donati K; Tacconelli E; Scoppettuolo G; Posteraro B; Fadda G; Cauda R; Tumbarello M
J Chemother; 2004 Apr; 16(2):172-8. PubMed ID: 15216953
[TBL] [Abstract][Full Text] [Related]
2. Candidemia at selected Canadian sites: results from the Fungal Disease Registry, 1992-1994. Fungal Disease Registry of the Canadian Infectious Disease Society.
Yamamura DL; Rotstein C; Nicolle LE; Ioannou S
CMAJ; 1999 Feb; 160(4):493-9. PubMed ID: 10081465
[TBL] [Abstract][Full Text] [Related]
3. Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome.
Dimopoulos G; Ntziora F; Rachiotis G; Armaganidis A; Falagas ME
Anesth Analg; 2008 Feb; 106(2):523-9, table of contents. PubMed ID: 18227310
[TBL] [Abstract][Full Text] [Related]
4. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
[TBL] [Abstract][Full Text] [Related]
5. Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals.
Bassetti M; Trecarichi EM; Righi E; Sanguinetti M; Bisio F; Posteraro B; Soro O; Cauda R; Viscoli C; Tumbarello M
Diagn Microbiol Infect Dis; 2007 Jul; 58(3):325-31. PubMed ID: 17350205
[TBL] [Abstract][Full Text] [Related]
6. Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study.
Lin MY; Carmeli Y; Zumsteg J; Flores EL; Tolentino J; Sreeramoju P; Weber SG
Antimicrob Agents Chemother; 2005 Nov; 49(11):4555-60. PubMed ID: 16251295
[TBL] [Abstract][Full Text] [Related]
7. Fungemia in non-HIV-infected patients: a five-year review.
Anunnatsiri S; Chetchotisakd P; Mootsikapun P
Int J Infect Dis; 2009 Jan; 13(1):90-6. PubMed ID: 18653367
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for candidemia-related mortality at a medical center in central Taiwan.
Cheng YR; Lin LC; Young TG; Liu CE; Chen CH; Tsay RW
J Microbiol Immunol Infect; 2006 Apr; 39(2):155-61. PubMed ID: 16604249
[TBL] [Abstract][Full Text] [Related]
9. Community-onset candidemia at a university hospital, 1995-2005.
Kung HC; Wang JL; Chang SC; Wang JT; Sun HY; Hsueh PR; Chen YC
J Microbiol Immunol Infect; 2007 Aug; 40(4):355-63. PubMed ID: 17712471
[TBL] [Abstract][Full Text] [Related]
10. Nosocomial candidemia: risk factors and attributable mortality.
Wenzel RP
Clin Infect Dis; 1995 Jun; 20(6):1531-4. PubMed ID: 7548504
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of epidemiological characteristics and risk factors of candidemia in adult patients in a tertiary-care hospital].
Yenigün Koçak B; Kuloğlu F; Doğan Çelik A; Akata F
Mikrobiyol Bul; 2011 Jul; 45(3):489-503. PubMed ID: 21935782
[TBL] [Abstract][Full Text] [Related]
12. Distribution and epidemiology of Candida species causing fungemia at a Saudi Arabian hospital, 1996-2004.
Al-Tawfiq JA
Int J Infect Dis; 2007 May; 11(3):239-44. PubMed ID: 16859945
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of candidemia in intensive care units.
Bouza E; Muñoz P
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S87-91. PubMed ID: 19013346
[TBL] [Abstract][Full Text] [Related]
14. Breakthrough candidemia in patients with cancer differs from de novo candidemia in host factors and Candida species but not intensity.
Kontoyiannis DP; Reddy BT; Hanna H; Bodey GP; Tarrand J; Raad II
Infect Control Hosp Epidemiol; 2002 Sep; 23(9):542-5. PubMed ID: 12269454
[TBL] [Abstract][Full Text] [Related]
15. Candidemia: a nosocomial complication in adults with late-stage AIDS.
Launay O; Lortholary O; Bouges-Michel C; Jarrousse B; Bentata M; Guillevin L
Clin Infect Dis; 1998 May; 26(5):1134-41. PubMed ID: 9597242
[TBL] [Abstract][Full Text] [Related]
16. Active surveillance for candidemia, Australia.
Chen S; Slavin M; Nguyen Q; Marriott D; Playford EG; Ellis D; Sorrell T;
Emerg Infect Dis; 2006 Oct; 12(10):1508-16. PubMed ID: 17176564
[TBL] [Abstract][Full Text] [Related]
17. Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections.
Safdar A; Hanna HA; Boktour M; Kontoyiannis DP; Hachem R; Lichtiger B; Freireich EJ; Raad II
Cancer; 2004 Dec; 101(12):2859-65. PubMed ID: 15529309
[TBL] [Abstract][Full Text] [Related]
18. Secular trends of candidemia in a large tertiary-care hospital from 1988 to 2000: emergence of Candida parapsilosis.
San Miguel LG; Cobo J; Otheo E; Sánchez-Sousa A; Abraira V; Moreno S
Infect Control Hosp Epidemiol; 2005 Jun; 26(6):548-52. PubMed ID: 16018430
[TBL] [Abstract][Full Text] [Related]
19. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR
Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669
[TBL] [Abstract][Full Text] [Related]
20. Candidemia in women with breast carcinoma treated with high-dose chemotherapy and autologous bone marrow transplantation.
Gottfredsson M; Vredenburgh JJ; Xu J; Schell WA; Perfect JR
Cancer; 2003 Jul; 98(1):24-30. PubMed ID: 12833451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
